Medicenna Therapeutics Corp.
(MENAFN- Baystreet) 09:47 AM EST - Medicenna Therapeutics Corp.: Today reported financial results and corporate highlights for the fiscal quarter ended September 30, 2026. Net loss for the quarter was $4.0 million, or $0.04 per share, compared with a net loss of $4.9 million, or $0.06 per share, for the corresponding period in 2025. Medicenna Therapeutics Corp.
shares T are trading down $0.005 at $0.36.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.

Comments
No comment